A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y.
Chief Judge Elizabeth Wolford of U.S. District Court for the District of Western New York last week ordered that oral arguments be held on two community health centers’ motion to be allowed to file an amended antitrust complaint against AstraZeneca, Lilly, Novo Nordisk, and Sanofi.
A once-dead lawsuit that accuses drug makers of colluding to deny 340B pricing on insulin and diabetes drugs shipped to contract pharmacies is going to be heard July 20 in federal district court in Rochester, N.Y. Chief Judge Elizabeth Wolford […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
